| Literature DB >> 30033322 |
Bapi Gorain1, Hira Choudhury2, Manisha Pandey2, Prashant Kesharwani3.
Abstract
Localised and targeted potential of nanocarrier for the eminent anticancer agent paclitaxel (PTX) could provide a great platform towards improvement of efficacy with reduction in associated toxicities, whereas incorporation of TPGS could further facilitate delivery in MDR through alteration of its inherent physicochemical properties. Current article therefore puts into perspective on nanocarrier-based recent researches of PTX with special stress towards TPGS-nanoparticle-mediated delivery in the improvement of cancer treatment and then accompanied with the discussion on distinct influence of the fabrication process. Such dynamic fabrications of the nanoparticulate therapy stimulate cellular interaction with frontier area for future research in tumor targeting potential.Entities:
Keywords: Drug delivery; EPR effect; Nanocarrier; Nanoparticles (NP); Paclitaxel; Vitamin-E-TPGS
Mesh:
Substances:
Year: 2018 PMID: 30033322 DOI: 10.1016/j.msec.2018.05.054
Source DB: PubMed Journal: Mater Sci Eng C Mater Biol Appl ISSN: 0928-4931 Impact factor: 7.328